Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmadrug Inc C.PHRX

Alternate Symbol(s):  LMLLF

Medical Care Cannabis
PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases (including Covid-19) and rare cancers. In clinical research, Cepharanthine exhibits multiple pharmacological effects, including anti-oxidative, anti-inflammatory, immuno-regulatory, anti-cancer, anti-viral and anti-parasitic properties. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions.


CSE:PHRX - Post by User

Pharmadrug Inc > Excuses promises and not so much else
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(4)
•••
Comment by JonDoughZillaon May 19, 2021 2:54pm
35 Views
Post# 33231302

RE:RE:RE:RE:RE:Excuses promises and not so much else

RE:RE:RE:RE:RE:Excuses promises and not so much elseJonDoughZilla wrote:

Get back to us when you have some actual results of success for "the long awaited opening of online store. "  We are tired of the verbal diarrhorea you spew when you don't have any real facts. People here don't want to die of old age waiting for the online store to ramp up sales to something respectable.

Sam you are not very good at following simple instructions.  You got back to us but you didn't wait for any evidence of success like maybe some sale. 

The the verbal diarrhorea you spew is all about your deranged preoccupation with LionWhisterer.  Readers here are not interested with your childish LW insults.  They are not working.  He is laughing at your futile insults.  He is immune to insults from Sam, Goldy and Frog.

Now get that online store info before you post again.  Capiche?

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities